The Division of Bioengineering and Machine Learning integrates engineering innovation with artificial intelligence to revolutionize cancer research and treatment.

By combining advanced computational modeling, machine learning, and biomedical engineering, the division develops smart tools and technologies that enhance cancer diagnosis, therapy, and patient monitoring.

Our researchers design bioengineered systems for targeted drug delivery, tissue modeling, and biomarker detection, while leveraging machine learning to analyze complex biological data and predict treatment outcomes. Through this synergy of engineering and data science, the division enables more precise, efficient, and personalized approach to cancer care.

Collaborating across disciplines, the Division of Bioengineering and Machine Learning drives innovation at the intersection of technology and medicine to accelerate progress in cancer research.